Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Retained Earnings: 2016-2025

Historic Retained Earnings for Tg Therapeutics (TGTX) over the last 10 years, with Sep 2025 value amounting to -$1.1 billion.

  • Tg Therapeutics' Retained Earnings rose 30.93% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year increase of 30.93%. This contributed to the annual value of -$1.5 billion for FY2024, which is 1.51% up from last year.
  • Per Tg Therapeutics' latest filing, its Retained Earnings stood at -$1.1 billion for Q3 2025, which was up 26.33% from -$1.5 billion recorded in Q2 2025.
  • In the past 5 years, Tg Therapeutics' Retained Earnings ranged from a high of -$1.1 billion in Q1 2021 and a low of -$1.6 billion during Q2 2023.
  • For the 3-year period, Tg Therapeutics' Retained Earnings averaged around -$1.5 billion, with its median value being -$1.5 billion (2024).
  • As far as peak fluctuations go, Tg Therapeutics' Retained Earnings plummeted by 46.21% in 2021, and later soared by 30.93% in 2025.
  • Quarterly analysis of 5 years shows Tg Therapeutics' Retained Earnings stood at -$1.3 billion in 2021, then decreased by 14.93% to -$1.5 billion in 2022, then decreased by 1.67% to -$1.6 billion in 2023, then increased by 1.51% to -$1.5 billion in 2024, then soared by 30.93% to -$1.1 billion in 2025.
  • Its Retained Earnings stands at -$1.1 billion for Q3 2025, versus -$1.5 billion for Q2 2025 and -$1.5 billion for Q1 2025.